Compare HSBC Holdings plc (HSBC) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HSBC Holdings plc vs Medpace Holdings Inc — how do they compare? HSBC Holdings plc trades at $101.09 (market cap $335.21B), while Medpace Holdings Inc trades at $530.22 (market cap $15.08B). The key difference: HSBC Holdings plc is far larger — about 22.2× Medpace Holdings Inc's market cap, and HSBC Holdings plc pays a 3.79% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| HSBC | MEDP | |
|---|---|---|
Market Cap | $335.21B | $15.08B |
Sector | Technology | Technology |
52-Week High | $100.61 | $620.59 |
52-Week Low | $61.30 | $308.88 |
Dividend Yield | 3.79% | — |
Enterprise Value | — | $14.55B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HSBC Holdings plc
HSBC is one of the world's largest banking and financial services organizations. It serves customers worldwide through four global businesses: Retail, Commercial, Global Banking, and Private Banking.
Read more on HSBC →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
